BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 25503582)

  • 1. STAT3 restrains RANK- and TLR4-mediated signalling by suppressing expression of the E2 ubiquitin-conjugating enzyme Ubc13.
    Zhang H; Hu H; Greeley N; Jin J; Matthews AJ; Ohashi E; Caetano MS; Li HS; Wu X; Mandal PK; McMurray JS; Moghaddam SJ; Sun SC; Watowich SS
    Nat Commun; 2014 Dec; 5():5798. PubMed ID: 25503582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune regulator LGP2 targets Ubc13/UBE2N to mediate widespread interference with K63 polyubiquitination and NF-κB activation.
    Lenoir JJ; Parisien JP; Horvath CM
    Cell Rep; 2021 Dec; 37(13):110175. PubMed ID: 34965427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL.
    Lamothe B; Campos AD; Webster WK; Gopinathan A; Hur L; Darnay BG
    J Biol Chem; 2008 Sep; 283(36):24871-80. PubMed ID: 18617513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
    Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
    J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-conjugating enzyme Ubc13 is a critical component of TNF receptor-associated factor (TRAF)-mediated inflammatory responses.
    Fukushima T; Matsuzawa S; Kress CL; Bruey JM; Krajewska M; Lefebvre S; Zapata JM; Ronai Z; Reed JC
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6371-6. PubMed ID: 17404240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF6-mediated ubiquitination of MST1/STK4 attenuates the TLR4-NF-κB signaling pathway in macrophages.
    Roh KH; Lee Y; Yoon JH; Lee D; Kim E; Park E; Lee IY; Kim TS; Song HK; Shin J; Lim DS; Choi EJ
    Cell Mol Life Sci; 2021 Mar; 78(5):2315-2328. PubMed ID: 32975614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.
    Yang Y; Yin C; Pandey A; Abbott D; Sassetti C; Kelliher MA
    J Biol Chem; 2007 Dec; 282(50):36223-9. PubMed ID: 17947236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An RNA-binding protein alphaCP-1 is involved in the STAT3-mediated suppression of NF-kappaB transcriptional activity.
    Nishinakamura H; Minoda Y; Saeki K; Koga K; Takaesu G; Onodera M; Yoshimura A; Kobayashi T
    Int Immunol; 2007 May; 19(5):609-19. PubMed ID: 17383969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-κB pathways and protects mice from lethal endotoxin shock.
    Rim HK; Cho W; Sung SH; Lee KT
    J Pharmacol Exp Ther; 2012 Sep; 342(3):654-64. PubMed ID: 22637723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human T-cell leukemia virus type 1 Tax oncoprotein requires the ubiquitin-conjugating enzyme Ubc13 for NF-kappaB activation.
    Shembade N; Harhaj NS; Yamamoto M; Akira S; Harhaj EW
    J Virol; 2007 Dec; 81(24):13735-42. PubMed ID: 17942533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization-primed coiled-coil domain interaction with Ubc13 confers processivity to TRAF6 ubiquitin ligase activity.
    Hu L; Xu J; Xie X; Zhou Y; Tao P; Li H; Han X; Wang C; Liu J; Xu P; Neculai D; Xia Z
    Nat Commun; 2017 Oct; 8(1):814. PubMed ID: 28993672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The deubiquitinase OTUB1 augments NF-κB-dependent immune responses in dendritic cells in infection and inflammation by stabilizing UBC13.
    Mulas F; Wang X; Song S; Nishanth G; Yi W; Brunn A; Larsen PK; Isermann B; Kalinke U; Barragan A; Naumann M; Deckert M; Schlüter D
    Cell Mol Immunol; 2021 Jun; 18(6):1512-1527. PubMed ID: 32024978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting TRAF6 E3 ligase activity with a small-molecule inhibitor combats autoimmunity.
    Brenke JK; Popowicz GM; Schorpp K; Rothenaigner I; Roesner M; Meininger I; Kalinski C; Ringelstetter L; R'kyek O; Jürjens G; Vincendeau M; Plettenburg O; Sattler M; Krappmann D; Hadian K
    J Biol Chem; 2018 Aug; 293(34):13191-13203. PubMed ID: 29950522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
    Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
    Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2 Polyubiquitin-conjugating enzyme Ubc13 in keratinocytes is essential for epidermal integrity.
    Sayama K; Yamamoto M; Shirakata Y; Hanakawa Y; Hirakawa S; Dai X; Tohyama M; Tokumaru S; Shin MS; Sakurai H; Akira S; Hashimoto K
    J Biol Chem; 2010 Sep; 285(39):30042-9. PubMed ID: 20663875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uev1A-Ubc13 catalyzes K63-linked ubiquitination of RHBDF2 to promote TACE maturation.
    Zhang Y; Li Y; Yang X; Wang J; Wang R; Qian X; Zhang W; Xiao W
    Cell Signal; 2018 Jan; 42():155-164. PubMed ID: 29069608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.
    Lamothe B; Besse A; Campos AD; Webster WK; Wu H; Darnay BG
    J Biol Chem; 2007 Feb; 282(6):4102-12. PubMed ID: 17135271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
    Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
    Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.